CURACLE and Théa Announce Licensing and Collaboration Agreement for the Development and Commercialization of Orally Administered Treatment for Diabetic Macular Edema and Wet-AMD

SEOUL, South Korea--(BUSINESS WIRE)--CURACLE signs tech licensing and collaboration deal with leading independent European ophthalmology company Théa in diabetic macular edema and wet-AMD

Full Story →